News

Amber Ent Says: From Concall:

In Consumer Durable Division, H2 Will Continue To See Double-digit Growth

In FY26, Cons Durable Biz May See 13-15% Growth Vs 15% In H1FY26

Commercial AC Continued Growth Momentum

For Electronics Division, Margin To Be 8-9% By Year-end & In Double-digit By FY27

Confident Of Doubling Revenue From Railway Sub-system & Defence In 2 Yrs

The stock is currently up 3.7%

The company reported a strong Q2 FY26 performance with net profit up 41.3% YoY to ₹637 crore, beating estimates. Revenue rose 27.2% to ₹3,170 crore, driven by robust demand across segments.

Shares of Interarch Building Solutions Ltd. are trading with gains of 12% on Friday, November 7, in response to its September quarter results, which were reported after market hours on Thursday.

Interarch’s revenue increased by 52% from last year to ₹491.1 crore, while its Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) increased to ₹41.7 crore, which is a 65% jump from the ₹25.3 crore it reported during the same quarter last year.

here

Suneeta Reddy, Managing Director, Apollo Hospitals Q2, On CNBC-TV18:

Healthcare Services Business Grew 9% This Quarter

Avg Revenue Per Patient Up 9% Driven By Growth In High-end Surgeries

Looking At Other Countries Such As Indonesia, Brunei For Medical Tourism

International Patient Revenue Accounts For 5% Of Sales

Have Made Some Decisions After Productive Discussions With Insurance Cos

Price Hikes By Hospitals Will Be Inflation And Risk Adjusted

Hospital Charges In India Are Already 1/10th Of Global Average

Further Cuts Could Affect Healthcare Quality

We Are Focussing On Restructuring Apollo Health And Lifestyle This Quarter

Opening Over 1,000 Beds In Next 1 Year, Started Pune Operations

Total EBITDA (Aluminium +Utkal +Copper) CNBC-TV18 Poll At Rs 5,350 cr

Aluminium EBITDA CNBC-TV18 Poll At Rs 4,680 cr

Copper Biz EBITDA CNBC-TV18 Poll At Rs 670 cr

Shares of Multi Commodity Exchange (MCX) of India Ltd. opened as much as 5% lower on Friday, November 7, after global brokerage firm Morgan Stanley maintained an ‘Underweight’ rating on the stock, with a target price of ₹5,860.

The target implies a potential downside of 37% from MCX’s last closing price.

Morgan Stanley said MCX’s Q2 profit after tax (PAT) was in line with estimates, while core EBITDA (excluding non-operating income) also met expectations despite a 2% reduction in cost.

here

The stock is currently up 11.11% post earnings.

The stock is currently down 2.7% at the moment.

The company reported a 13.4% YoY rise in Q2 net profit to ₹1,021 crore, with revenue up 10.3% to ₹3,365 crore. EBITDA grew 12.4% to ₹2,027 crore, and margins improved to 60.2%.

The stock is currently up 5.5%.

The company reported a strong set of numbers for the July-September quarter (Q2 FY26), with net profit rising to ₹106 crore, nearly double the ₹52 crore recorded in the same period last year.

Revenue from operations increased 12% year-on-year to ₹2,100 crore, compared with ₹1,628 crore a year ago. EBITDA grew 47.7% to ₹291 crore, while the EBITDA margin improved to 13.9% from 12.1%, supported by better realisations and operational efficiencies.

here

Shares of Amber Enterprises Ltd. declined nearly 10% in early trade on Friday, October 7, after the company reported weak set of earnings, missing estimates on all fronts.

The company’s revenue declined slightly and it slipped into a loss in the second quarter compared to a profit in the base quarter. Overall, its margins declined 120 basis points, and were under pressure in all three segments — consumer durables, electronics, railway sub-sytem & defence.

here

CLSA On Aurobindo Pharma:

Outperform Call, Target Price At Rs 1,340/Sh

Q2 Revenue In-line, PAT Missed On Margin

Strong Growth In Europe Offset By Weak US & API Business

Maintained FY26 Revenue & Margin Guidance

Nomura On Zydus Lifesciences:

Buy Call, Target Price At Rs 1,140/Sh

Q2 Beat Estimates, With PAT 34% Higher On Forex Gains

India Business Outperformed, US Revenue Missed Slightly

EBITDA Also Ahead Of Estimates

Nomura On Birlasoft:

Neutral Call, Target Price At Rs 350/Sh

Q2FY26 Revenue In-line With The Estimates

Focus On Deal Wins, Margin Improvement & Operational Efficiency

Management Prioritising Predictability Restoration

Net Profit down 2.6% At Rs 370 Cr Vs Rs 380 Cr (QoQ)

Revenue up 6.8% At Rs 3,483.6 Cr Vs Rs 3,261 Cr (QoQ)

EBITDA up 48.7% At Rs 601.4 Cr Vs Rs 404.5 Cr (QoQ)

Margin At 17.26% Vs 12.41% (QoQ)

Board Approves Acqn Of CyberSolve Group Cos For Rs 585 Cr

CC Rev Growth At 3.4% QoQ & 5.2% YoY

$ Rev Up 3.3% QoQ & Up 5.5% YoY At $394.8 m

Shares of Amber Enterprises Ltd. are in focus on Friday, October 7, after the company reported weak set of earnings, missing estimates on all fronts.

The company’s revenue declined slightly and it slipped into a loss in the second quarter compared to a profit in the base quarter. Overall, its margins declined 120 basis points, and were under pressure in all three segments — consumer durables, electronics, railway sub-sytem & defence.

here

The company reported a strong Q2 FY26 performance with net profit rising 25% YoY to ₹494 crore, beating estimates. Revenue grew 12.8% to ₹6,303 crore, driven by healthcare and digital segments.

The consumer electricals company reported a 43% YoY drop in Q2 net profit to ₹71 crore, while revenue rose 1% to ₹1,915 crore. EBITDA declined 22.6% to ₹158 crore due to higher costs and pricing pressures.

The company reported an 18% YoY rise in net profit to ₹643 crore, with revenue up 17.4% to ₹2,614 crore. Asset quality stayed stable, while provisions rose to ₹50 crore from ₹5 crore last year.

Welcome to CNBC-TV18’s LIVE Blog on the September quarter earnings. Check this space for minute-by-minute updates on earnings, stock reactions, management commentary, guidance and more.NewsLive TVMarketPopular CategoriesCalculatorsTrending NowLet's Connect with CNBCTV 18Network 18 Group :©TV18 Broadcast Limited. All rights reserved.